Role of Naloxone in OpioidOverdose Fatality Prevention; Workshop; Request for Comments
Document ID: FDA-2011-N-0802-0001
Comments
Total: 37
-
Rudolph Joseph Maier, MD - Comment
Posted : 02/28/2012 ID ：FDA-2011-N-0802-0002 Agency : FDA -
Jun 12,2012 11:59 PM ET
-
Pain Treatment Topics (Pain-Topics.org) - Comment
Posted : 04/12/2012 ID ：FDA-2011-N-0802-0003 Agency : FDA -
Jun 12,2012 11:59 PM ET
-
Hillary Dubois - Comment
Posted : 04/12/2012 ID ：FDA-2011-N-0802-0004 Agency : FDA -
Jun 12,2012 11:59 PM ET
-
mark eisenberg - Comment
Posted : 04/12/2012 ID ：FDA-2011-N-0802-0005 Agency : FDA -
Jun 12,2012 11:59 PM ET
-
Mary Kay Borgstrom - Comment
Posted : 04/12/2012 ID ：FDA-2011-N-0802-0006 Agency : FDA -
Jun 12,2012 11:59 PM ET
-
Jeffrey Joseph Cece - Comment
Posted : 04/12/2012 ID ：FDA-2011-N-0802-0007 Agency : FDA -
Jun 12,2012 11:59 PM ET
-
Maya Doe-Simkins - Comment
Posted : 05/02/2012 ID ：FDA-2011-N-0802-0008 Agency : FDA -
Jun 12,2012 11:59 PM ET
-
Keith Brown - Comment
Posted : 05/17/2012 ID ：FDA-2011-N-0802-0009 Agency : FDA -
Jun 12,2012 11:59 PM ET
-
Destry Gabrielle Taylor, RN, BSN, MSN-c - Comment
Posted : 05/17/2012 ID ：FDA-2011-N-0802-0010 Agency : FDA -
Jun 12,2012 11:59 PM ET
-
Robert Childs, MPH - Comment
Posted : 05/17/2012 ID ：FDA-2011-N-0802-0011 Agency : FDA -
Jun 12,2012 11:59 PM ET
-
Suzanne Doyon - Comment
Posted : 06/13/2012 ID ：FDA-2011-N-0802-0012 Agency : FDA -
Jun 12,2012 11:59 PM ET
-
Open Society Foundations (OSF) - Comment
Posted : 06/13/2012 ID ：FDA-2011-N-0802-0013 Agency : FDA -
Jun 12,2012 11:59 PM ET
-
National Alliance of State & Territorial AIDS Directors - Comment
Posted : 06/13/2012 ID ：FDA-2011-N-0802-0014 Agency : FDA -
Jun 12,2012 11:59 PM ET
-
American Society of Addiction Medicine (ASAM) - Comment
Posted : 06/13/2012 ID ：FDA-2011-N-0802-0015 Agency : FDA -
Jun 12,2012 11:59 PM ET
-
Erin K Gibson - Comment
Posted : 06/13/2012 ID ：FDA-2011-N-0802-0016 Agency : FDA -
Jun 12,2012 11:59 PM ET
-
Baltimore City Health Department - Comment
Posted : 06/13/2012 ID ：FDA-2011-N-0802-0017 Agency : FDA -
Jun 12,2012 11:59 PM ET
-
Alice Bell - Comment
Posted : 06/13/2012 ID ：FDA-2011-N-0802-0018 Agency : FDA -
Jun 12,2012 11:59 PM ET
-
Jess Tilley - Comment
Posted : 06/13/2012 ID ：FDA-2011-N-0802-0019 Agency : FDA -
Jun 12,2012 11:59 PM ET
-
Stephen Roussel - Comment
Posted : 06/13/2012 ID ：FDA-2011-N-0802-0020 Agency : FDA -
Jun 12,2012 11:59 PM ET
-
Liz Whynott - Comment
Posted : 06/13/2012 ID ：FDA-2011-N-0802-0021 Agency : FDA -
Jun 12,2012 11:59 PM ET
-
University of California San Diego - Comment
Posted : 06/14/2012 ID ：FDA-2011-N-0802-0022 Agency : FDA -
Jun 12,2012 11:59 PM ET
-
Christopher Heneghan - Comment
Posted : 06/14/2012 ID ：FDA-2011-N-0802-0023 Agency : FDA -
Jun 12,2012 11:59 PM ET
-
Addiction Recovery Council of Virginia, ARCVA - Comment
Posted : 06/14/2012 ID ：FDA-2011-N-0802-0024 Agency : FDA -
Jun 12,2012 11:59 PM ET
-
Northeastern University School of Law - Comment
Posted : 06/14/2012 ID ：FDA-2011-N-0802-0025 Agency : FDA -
Jun 12,2012 11:59 PM ET
-
Avery A Lenhart - Comment
Posted : 06/14/2012 ID ：FDA-2011-N-0802-0026 Agency : FDA -
Jun 12,2012 11:59 PM ET
-
Brown Medical School/Lifespan - Comment
Posted : 06/14/2012 ID ：FDA-2011-N-0802-0027 Agency : FDA -
Jun 12,2012 11:59 PM ET
-
Harm Reduction Coalition - Comment
Posted : 06/14/2012 ID ：FDA-2011-N-0802-0028 Agency : FDA -
Jun 12,2012 11:59 PM ET
-
Holly Catania - Comment
Posted : 06/14/2012 ID ：FDA-2011-N-0802-0029 Agency : FDA -
Jun 12,2012 11:59 PM ET
-
Norman Wetterau, MD - Comment
Posted : 06/14/2012 ID ：FDA-2011-N-0802-0030 Agency : FDA -
Jun 12,2012 11:59 PM ET
-
Alexander Staub Bennett - Comment
Posted : 06/14/2012 ID ：FDA-2011-N-0802-0031 Agency : FDA -
Jun 12,2012 11:59 PM ET